|
Įkelta: 2012-01-21 Peržiūrėjo: 8 Patiko: Quest Diagnostics (DGX) Stratify JCV gets de novo classification from FDAQuest Diagnostics - DGX - reported that the FDA has granted a de novo classification petition to its STRATIFY JCV Antibody ELISA testing service KomentaraiPrašome palaukti...
|
Prisijungti su epasas.ltĮkėlė
|
Naujienos





















